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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To determine the effectiveness of electrical stimulation with non-implanted electrodes in comparison with placebo or any other active
treatment in adults with overactive bladder with or without urgency urinary incontinence.
B A C K G R O U N D
Description of the condition
Overactive bladder is a chronic disorder with an overall prevalence
in the adult population of over 10%, but that may exceed 40% in
elderly groups (Irvin 2006). According to the International Conti-
nence Society, overactive bladder is characterised by symptoms of
urinary urgency (a strong compelling desire to urinate that is dif-
ficult to overcome), with or without urinary incontinence. Over-
active bladder is usually accompanied by daytime frequency (in-
creased need to urinate) and nocturia (waking during the night to
urinate), but without urinary infection or other bladder patholo-
gies (Abrams 2003).Overactive bladder with urinary incontinence
is known as overactive bladder wet; overactive bladder without
incontinence is known as overactive bladder dry.
Urinary incontinence has many psychosocial implications. It ap-
pears that overactive bladder has a greater psychological impact
than stress urinary incontinence, with 60% of overactive bladder
patients reporting a history of depression compared with 14% of
patients with stress urinary incontinence (Zorn 1999).
The aetiology of overactive bladder is multifactorial, with urgency
symptoms associatedwith overactivity of the detrusormuscle. This
overactivity can be related to neurogenic, myogenic, or idiopathic
origins (Shaw 2011). However, currently its aetiology is unclear.
Description of the intervention
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Conservative management, such as bladder training or pelvic floor
muscle exercises, has been recommended as a first-line treatment
for overactive bladder (Abrams 2003).
Themain type of medical treatment for overactive bladder is phar-
macotherapy with anticholinergics, which have proven to be ef-
fective in several randomised controlled trials (RCTs). However,
common side effects such as dry mouth and constipation limit
long-term compliance, with discontinuation rates of 70% to 90%
within one year (D´ Souza 2008). Intravesical botulinum toxin
injections may be an effective and safe option to treat refractory
overactive bladder but further controlled studies are required to
evaluate its effectiveness (Duthie 2011). This is considered to be
a surgical intervention in this review.
In patients for whom conservative or drug treatment is not suffi-
cient, neuromodulation is an alternative. Neuromodulation uses
electrical stimulation to target specific nerves in the sacral plexus
that control pelvic floor function.
Electrical stimulation can be used to treat overactive bladder via
different routes, such as implantable or internal (sacral neuromod-
ulation) and non-implantable electrodes, typically vaginal, rectal
(anal) or skin electrodes.
Electrical stimulation can be used on its own or in association
with pelvic floor muscle exercises, often indicated in stress urinary
incontinence and overactive bladder.
This review includes non-implanted electrodes only; implanted
devices are included in another Cochrane systematic review
(Herbison 2009).
Intracavitary (vaginal or rectal) electrical stimulation
Intravaginal electrical stimulation
Intravaginal electrical stimulation for treating urinary inconti-
nence was first reported in the literature in the 1960s (Cadwell
1963). Subsequently, it has been shown to achieve satisfactory re-
sults with frequencies below 12 Hertz (Hz) stimulating the pu-
dendal nerve, which may inhibit the detrusor muscle, reduce in-
voluntary contractions and, consequently, reduce the number of
micturitions (Messelink 1999). Electrical stimulation also works
in a passive way, helping patients become conscious of the perineal
muscle contraction and this may, in turn, help to inhibit detrusor
involuntary contractions (Amaro 2003).
The contraindications to intravaginal electrical stimulation are
pregnancy, vaginal infection or lesion, a reduced perception
of vaginal sensation, menstruation, and metallic implants (
Richardson 1996).
Rectal (anal) electrical stimulation
Electrodes inserted in the rectal canal inhibit detrusor contrac-
tions through contact with the pudendal nerve afferent fibres and
thus may be effective in the treatment of urgency urinary incon-
tinence and overactive bladder. Rectal electrical stimulation has
achieved some favourable results in treating faecal incontinence
(Scott 2014). A short-term study of rectal electrical stimulation
reported some benefits in treating men with urinary incontinence
(Berghmans 2013).
Posterior tibial nerve stimulation
Transcutaneous and percutaneous neuromodulation of the tibial
nerve can be delivered over either the sacral outflow or peroneal
region of the ankle through surface electrodes (ICI 2012).
Transcutaneous electrical nerve stimulation
Transcutaneous electrical nerve stimulation is aminimally invasive
treatment which delivers an electrical current through an electrode
placed in the ischiorectal area. Transcutaneous electrical nerve
stimulation has been shown to be safe and effective in the treat-
ment of overactive bladder (Bellette 2009). Multimodal treatment
could be more effective for improving overactive bladder symp-
toms. One study has shown better results when transcutaneous
electrical nerve stimulation was used with oxybutynin compared
to transcutaneous electrical nerve stimulation or oxybutynin alone
(Souto 2014).
Percutaneous tibial nerve stimulation
Percutaneous tibial nerve stimulation is a form of neuromodula-
tion that delivers retrograde stimulation to the sacral nerve plexus
via a needle electrode inserted into the ankle, cephalad to the me-
dial malleolus, an anatomical area recognised as the bladder centre.
A recent multicentre, randomised trial found that percutaneous
tibial nerve stimulation was more effective than 4mg extended
release tolterodine in the treatment of overactive bladder (Peters
2009). Other authors observed comparable improvement using
antimuscarinics; however, fewer side effects were observed when
percutaneous tibial nerve stimulation was used (Burton 2012).
How the intervention might work
Electrical stimulation inhibits detrusor contractions, decreasing
the number of micturitions and potentially increasing bladder ca-
pacity (Wang 2006). Electrodes can be located in the vaginal or
rectal canals in such a way as to obtain contact with a significant
quantity of afferent nerve fibres of the pudendal nerve. This stim-
ulation of the pudendal nerve activates the skeletal pelvic floor
muscles and inhibits detrusor contraction. Partial or total inner-
vation of the pudendal nerve is necessary so that nerve stimulation
can occur (Messelink 1999). The anal electrode can be used for
men or in cases where the vaginal approach is contraindicated.
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Evidence from clinical trials indicates that electrical stimulation
may show promise for treating overactive bladder. Ohlsson 1989
studied patients with detrusor overactivity treated with intravagi-
nal electrical stimulation and reported a significant increase in
bladder functional capacity, with 30% reporting a reduction in
the number of daily micturitions. A randomised controlled study
showed that intravaginal electrical stimulation was useful in treat-
ing patients with urinary incontinence due to detrusor overactiv-
ity (Yamanishi 2000). However, another study observed low effec-
tiveness of intravaginal electrical stimulation on the pelvic floor in
elderly women with urinary incontinence (Spruijt 2003).
Why it is important to do this review
Numerous treatment options exist for overactive bladder, includ-
ing behavioural therapies such as pelvic floor muscle rehabilita-
tion, bladder training, and dietary modification, as well as phar-
macological therapy and neuromodulation. Overall, behavioural
therapies are considered the mainstay of treatment for urinary in-
continence. It is known that overactive bladder can be improved
through behavioural therapy or drug treatment but it is not known
whether non-invasive electrical stimulation achieves better clini-
cal outcomes. This review aims to present an overview of current
evidence related to electrical stimulation in the treatment of over-
active bladder.
This systematic review aims to investigate the effects of non-im-
planted electrical stimulation in patients with overactive bladder or
urgency incontinence. It also aims to compare specific subgroups
to investigate whether electrical stimulation might be more bene-
ficial for some populations than for others.
O B J E C T I V E S
To determine the effectiveness of electrical stimulation with non-
implanted electrodes in comparison with placebo or any other
active treatment in adults with overactive bladder with or without
urgency urinary incontinence.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include RCTs, quasi-RCTs (RCTs in which allocation to
treatment is based on methods such as alternate medical records,
date of birth, or other predictable methods) and randomised cross-
over trials .
Types of participants
Eligible studies will include adults (≥18 years old, or according to
study authors’ definitions of adult) with either of the following:
• symptomatic diagnosis of overactive bladder, urgency
urinary incontinence or mixed urinary incontinence;
• urodynamic diagnosis of detrusor overactivity in addition
to overactive bladder symptoms (urgency, frequency or episodes
of urgency incontinence).
Studies including participants with stress urinary incontinence
with or without overactive bladder symptoms will be included if
data are reported separately for stress urinary incontinence and
overactive bladder participants, or if the majority of the popu-
lation have overactive bladder/urgency urinary incontinence-pre-
dominant symptoms.
Types of interventions
Eligible comparators will be any intervention intended to decrease
urinary frequency and will include placebo, sham treatment, con-
servative treatment (including complementary therapies), drugs
and surgery. We will also include studies comparing different elec-
trical stimulation methods to each other. There will be no restric-
tions by type of device, stimulation parameters (such as continu-
ous, interrupted, duration of stimulation), duration of treatment,
route of administration (e.g. vaginal, rectal, skin, pretibial area),
or other similar factors. We will exclude trials of different combi-
nations of treatments even if one of those is electrical stimulation
if it is not possible to identify the effect of this treatment alone
(e.g. electrical stimulation plus another treatment versus electrical
stimulation plus other combined treatments)
We will consider the following comparisons:
• electrical stimulation versus no active treatment, placebo or
sham treatment;
• electrical stimulation versus conservative treatment (e.g.
bladder training, pelvic floor muscle training, biofeedback,
magnetic stimulation);
• electrical stimulation versus drugs (e.g. anticholinergics);
• electrical stimulation versus surgery (including botulinum
toxin);
• electrical stimulation versus electrical stimulation plus
another treatment;
• electrical stimulation plus another treatment versus other
treatment alone;
• electrical stimulation plus another treatment versus no
active treatment, placebo or sham treatment;
• one type of electrical stimulation versus another.
Types of outcome measures
The following outcomes will be considered:
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Primary outcomes
• Perception of cure (number of participants with overactive
bladder symptoms; number of participants with self-reported
urgency urinary incontinence)
• Perception of improvement (number of participants with
no improvement in overactive bladder symptoms; number of
participants with no improvement in self-reported urgency
urinary incontinence)
• Quality of life measures due to overactive bladder or
incontinence (however defined by authors or by any validated
measurement scales such as International Consultation on
Incontinence Questionnaire)
Secondary outcomes
• Quantification of symptoms
◦ Number of incontinence episodes (per 24 hours)
◦ Number of urgency episodes (per 24 hours)
◦ Number of micturitions (per 24 hours)
◦ Number of nocturia episodes (per night)
◦ Number of pads used per 24 hours
◦ Pad tests (weights) (e.g. one hour pad test, 24 hour
pad test)
• Clinicians’ observations
◦ Number of participants with objectively measured
incontinence (such as observation of leakage, leakage observed at
urodynamics study)
◦ Number of participants with detrusor overactivity
observed at urodynamic study
◦ Bladder capacity measured by urodynamic study
• Socioeconomic measures
◦ Costs of interventions
◦ Cost-effectiveness of interventions
◦ Resource implications
• Procedure outcome measures
◦ Duration of procedure
◦ Length of hospital stay
◦ Time to return to normal activity level
• Adverse effects
◦ Skin damage
◦ Pain or discomfort
◦ Vascular, visceral or nerve injury
◦ Voiding dysfunction
◦ Other complications
• Other outcomes
◦ Non-prespecified outcomes judged important when
performing the review
Grading of Recommendations Assessment, Development
and Evaluation (GRADE) outcomes
Wewill include the following outcomes in a ’Summary of findings’
table:
• number of participants with no improvement in overactive
bladder symptoms or urgency symptoms;
• number of participants with no improvement in self-
reported urgency urinary incontinence;
• quality of life measures due to overactive bladder;
• adverse effects (pain or discomfort due to treatment);
• cost-effectiveness of interventions.
Search methods for identification of studies
We will not impose any restrictions, for example language or pub-
lication status, on the searches described below.
Electronic searches
This review will draw on the search strategy developed for the
Cochrane Incontinence Group. We will identify relevant trials
from theCochrane IncontinenceGroupSpecialisedTrialsRegister.
Formore details of the searchmethods used to build the Specialised
Register please see the Group’s module in The Cochrane Library.
The Register contains trials identified from the Cochrane Central
Register of Controlled Trials (CENTRAL), MEDLINE, MED-
LINE in process, ClinicalTrials.gov (https://clinicaltrials.gov/),
World Health Organization (WHO) International Clinical Trials
Registry Platform (ICTRP) Search Portal (http://apps.who.int/
trialsearch/) and handsearching of journals and conference pro-
ceedings. Most of the trials in the Cochrane Incontinence Group
Specialised Register are also contained in CENTRAL. Search
terms for the Incontinence Group Specialised Register are given
in Appendix 1.
A number of the review authors (OLFG, RE, MOG, AK, JLA)
will also search the following databases (Appendix 1):
• PubMed (from inception)
• CENTRAL (Cochrane Library);
• Embase on OvidSP (1980 onwards) and the Latin-
American and Caribbean Center on Health Sciencies
Information (LILACS) (on the Virtual Health Library/Bireme)
(1982 onwards). The highly sensitive Embase and LILACS
strategies for identification of RCTs (Castro 1997; Castro 1999;
Lefebvre 2011) will be combined with search terms relating to
the condition and interventions
• Information about ongoing clinical trials will be sought
from the clinical trials registries such as ClinicalTrials.gov and
the WHO International Clinical Trials Registry Platform (
WHO ICTRP).
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Searching other resources
We will screen reference lists of the identified relevant studies for
additional citations. In addition, we will contact clinical specialists
and authors of included trials where appropriate to obtain unpub-
lished data.
Data collection and analysis
Selection of studies
Two authors will independently screen the trials identified by the
literature search. We will resolve any disagreements by consulting
a third author.
Data extraction and management
Two authors will extract data independently. We will resolve any
discrepancies by discussion. We will use a pre-standardised data
extraction form to extract data pertaining to study characteristics
(design, methods of randomisation), participants, interventions
and outcomes.
Assessment of risk of bias in included studies
Two authors will independently assess risk of bias in included
trials using the Cochrane Collaboration’s tool for assessing risk
of bias (Higgins 2011), considering the following four domains:
random sequence generation, allocation concealment, blinding,
and incomplete outcome data. We will resolve any disagreements
by consulting a third author.
Measures of treatment effect
We will analyse included trial data as described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
(a) Binary outcomes
For dichotomous data, wewill calculate risk ratios (RRs) with 95%
confidence intervals (CIs).
(b) Continuous outcomes
For continuous data, we will present mean differences (MDs) with
95%CIs.We will calculate standardised mean differences (SMDs)
to combine trials thatmeasure the same outcomebutwith different
methods.
Unit of analysis issues
The unit of analysis will be each participant recruited into the
trials.
We will analyse studies with non-standard designs, such as cross-
over trials and cluster-randomised trials, as described in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011). We will analyse studies with multiple treatment groups by
treating each pair of arms as a separate comparison, as appropriate.
Where data from randomised cross-over trials are incomplete we
will consider including data from the first period of randomisation
only.
Dealing with missing data
We will analyse data on an intention-to-treat (ITT) basis, as far as
possible, whereby all participants must be analysed according to
the groups to which they were randomised. For individual trials
we will report whether or not analysis was performed according to
the ITTprinciple.Where participants are excluded after allocation
or withdraw from the trial, we will report any details provided in
full. Where data from randomised cross-over trials are incomplete
we will include data from the first period of randomisation only.
We will make all reasonable attempts to contact authors for clari-
fication of missing data. Where trials report mean values without
standard deviations (SDs) but with P values or 95% CIs, we will
use RevMan’s calculator to estimate the SDs. Where trials report
mean values only, we will assume the outcome to have a SD equal
to the highest SD from the other trials within the same analysis.
Assessment of heterogeneity
We will assess clinical heterogeneity by examination of the study
details and test for statistical heterogeneity between trial results
using the chi-squared test and the I2 statistic (Higgins 2011), using
the following I2 values:
• < 30% heterogeneity may not be important;
• 30% to 50% may represent moderate heterogeneity;
• > 50% may represent substantial or considerable
heterogeneity.
Assessment of reporting biases
We will assess the likelihood of potential publication bias using
funnel plots, provided that we identify 10 or more eligible trials.
Data synthesis
Wewill use Cochrane’s statistical software, ReviewManager 2014,
for data analysis. We will use the fixed-effect model to analyse
data. If significant heterogeneity (for example I2 higher than 50%)
is identified, we will compute pooled estimates of the treatment
effect for each outcome under a random-effects model (with two
or more studies).
If outcomes are reported which are similar to but not precisely the
same as pre-specified ones, we will consider whether to use ’sur-
rogate’ outcomes to substitute for missing data. For example, if a
trial has reported episodes of urinary incontinence without speci-
fying the type of incontinence, e.g. stress urinary incontinence or
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urgency urinary incontinence, we could use the data as a substi-
tute for urgency urinary incontinence. Similarly, we could use ’im-
provement in urgency symptoms’ as a substitute for ’improvement
in overactive bladder symptoms’. Finally, if a subjective outcome
(such as overactive bladder symptoms) is reported as combined
with an objective outcome (such as detrusor overactivity) without
reporting them separately we will consider using it as a surrogate
for the subjective outcome.
Subgroup analysis and investigation of heterogeneity
In the case of substantial heterogeneity (I2 > 50%), we will inves-
tigate the causes of heterogeneity and if data permit, we will carry
out the following subgroup analyses:
• participants with idiopathic overactive bladder versus those
with neurogenic overactive bladder;
• participants with overactive bladder and urgency urinary
incontinence only versus participants with mixed urinary
incontinence (urgency urinary incontinence and stress urinary
incontinence);
• approaches of electrodes (transcutaneous (e.g. perineal skin,
sacral, posterior pretibial nerve), endocavitary (vaginal, rectal,
urethral), and percutaneous (posterior pretibial nerve).
Sensitivity analysis
If data permit, we will perform a sensitivity analysis comparing
trials with low risk of selection bias to those with high risk of bias.
’Summary of findings’ table
We will apply the principles of the GRADE system to assess the
quality of the body of evidence associated with specific outcomes
(perception of cure, perception of improvement and overactive-
related quality of life) (Guyatt 2008). We will construct a ’Sum-
mary of findings’ table using the GRADEpro (GRADEproGDT)
software (http://www.guidelinedevelopment.org/). The GRADE
approach appraises the quality of a body of evidence based on the
extent to which one can be confident that an estimate of effect or
association reflects the item being assessed. The quality of a body
of evidence considers within-study risk of bias (methodological
quality), the directness of the evidence, heterogeneity of the data,
precision of effect estimates, and risk of publication bias.
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A P P E N D I C E S
Appendix 1. Search strategies
Incontinence Group Specialised Register
The terms that will be used to search the Incontinence Group Specialised Register are given below:
(({DESIGN.CCT*} OR {DESIGN.RCT*}) AND ({INTVENT.PHYS.ELECTSTIM*}) AND ({TOPIC.URINE.INCON*} OR
{TOPIC.URINE.OVERACTIVE*})
(All searches will be of the keyword field of Reference Manager 2012).
PubMed (from inception) and CENTRAL (Cochrane Library) (from inception)
The following search terms will be used:
((Overactive Bladder)OR (OveractiveUrinary Bladder)OR (OveractiveDetrusor)OR (OveractiveDetrusor Function)ORbladderOR
(urinary bladder) OR (unstable bladder) OR (urge incontinence) OR (inhibits bladder) OR (Urinary Reflex Incontinence) OR (Urinary
Urge Incontinence) OR (Urge Incontinence) OR (Urinary Bladder Disease) OR (Urinary Bladder Diseases) OR (Bladder Diseases) OR
(Bladder Disease)) AND ((Electrical Stimulation) OR (Electrical Stimulations) OR (Electric Stimulations) OR (Electric Stimulation)
OR (Electric Stimulation Therapy)OR (Therapeutic Electrical Stimulation) OR ElectrotherapyOR (Therapeutic Electric Stimulation)
OR (Electrical Stimulation Therapy) OR (Transcutaneous Electrical Stimulation) OR (Percutaneous Electric Nerve Stimulation) OR
(Percutaneous Electrical Nerve Stimulation) OR (Transdermal Electrostimulation) OR (Transcutaneous Electrical Nerve Stimulation)
OR (Transcutaneous Nerve Stimulation) OR (Transcutaneous Electric Stimulation) OR TENS OR Electroanalgesia OR (Analgesic
Cutaneous Electrostimulation))
Embase (OvidSP) (from 1980 onwards)
The search strategy that will be used in Embase is given below. The RCT terms (lines 1 and 2) are those recommended by Lefebvre
2011. The search will be limited to those records added to Embase from January 2010 onwards as earlier trials are included in the
Specialised Register search of CENTRAL.
1. (random$ or factorial$ or crossover$ or cross over$ or cross-over$ or placebo$ or (doubl$ adj blind$) or (singl$ adj blind$) or assign$
or allocat$ or volunteer$).tw.
2. (crossover-procedure or double-blind procedure or randomised controlled trial or single-blind procedure).sh.
3. 1 or 2
4. urine incontinence/ or mixed incontinence/ or stress incontinence/ or urge incontinence/
5. overactive bladder/
6. (Detrusor$ or bladder$ or incontinen$ or continen$).tw.
7. 4 or 5 or 6
8. (Electric$ Stimulation$ or Electric Stimulation or Electrotherap$ or TENS or Electroanalgesia or electrostimulation$ or nerve
stimulation$).tw.
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9. electrostimulation/
10. electrostimulation therapy/
11. transcutaneous nerve stimulation/
12. 8 or 9 or 10 or 11
13. 3 and 7 and 12
14. 2010$.em.
15. 2011$.em.
16. 2012$.em.
17. 2013$.em.
18. 14 or 15 or 16 or 17
19. 13 and 18
LILACS (Virtual Health Library/BIREME) (from 1982)
The terms that will be used to search LILACS are given below. The RCT terms are those developed by Castro and colleagues (Castro
1997; Castro 1999).
(Detrusor$ OR bladder$ OR incontinen$ OR continen$) [Words]
AND
((Electric$ Stimulation$) OR (Electric Stimulation) OR Electrotherap$ OR TENS OR Electroanalgesia OR electrostimulation$ OR
(nerve stimulation$)) [Words]
(nb for some reason if remove (electric stimulation) it retrieves less articles!!!)
((Pt randomised controlled trial OR Pt controlled clinical trial OR Mh randomised controlled trials OR Mh random allocation OR
Mh
double-blind method OR Mh single-blind method) AND NOT (Ct animal AND NOT (Ct human and Ct animal)) OR (Pt clinical
trial OR Ex E05.318.760.535$ OR (Tw clin$ AND (Tw trial$ OR Tw ensa$ OR Tw estud$ OR Tw experim$ OR Tw investiga$))
OR ((Tw singl$ OR Tw simple$ OR Tw doubl$ OR Tw doble$ OR Tw duplo$ OR Tw trebl$ OR Tw trip$) AND (Tw blind$ OR
Tw cego$ OR Tw ciego$ OR Tw mask$ OR Tw mascar$)) ORMh placebos OR Tw placebo$ OR (Tw random$ OR Tw randon$ OR
Tw casual$ OR Tw acaso$ OR Tw azar OR Tw aleator$) ORMh research design) ANDNOT (Ct animal ANDNOT (Ct human and
Ct animal)) OR (Ct comparative study OR Ex E05.337$ OR Mh follow-up studies OR Mh prospective studies OR Tw control$ OR
Tw prospectiv$ OR Tw volunt$ OR Tw volunteer$) AND NOT (Ct animal AND NOT (Ct human and Ct animal))) [Words]
Field = words
ClinicalTrials.gov and WHO ICTRP Search Portal
Ongoing clinical trials will be sought by searching the clinical trials sites from the National Institute of Health (ClinicalTrials.gov)
and the WHO International Clinical Trials Registry Platform (WHO ICTRP) using the search term: overactive bladder.
WH A T ’ S N E W
Date Event Description
9 September 2015 New citation required and minor changes The protocol has been amended.
9 September 2015 Amended The protocol has been amended.
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